nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—CYP2C9—Disulfiram—alcohol dependence	0.277	1	CbGbCtD
Eprosartan—ABCC2—bile—alcohol dependence	0.0212	0.309	CbGeAlD
Eprosartan—AGTR1—Allograft Rejection—PECR—alcohol dependence	0.00918	0.0712	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—OPRK1—alcohol dependence	0.00597	0.0464	CbGpPWpGaD
Eprosartan—AGTR1—forebrain—alcohol dependence	0.00456	0.0666	CbGeAlD
Eprosartan—AGTR1—adrenal cortex—alcohol dependence	0.00423	0.0617	CbGeAlD
Eprosartan—AGTR1—Peptide GPCRs—OPRD1—alcohol dependence	0.00401	0.0312	CbGpPWpGaD
Eprosartan—AGTR1—cardiovascular system—alcohol dependence	0.00386	0.0563	CbGeAlD
Eprosartan—AGTR1—Peptide GPCRs—OPRM1—alcohol dependence	0.00309	0.024	CbGpPWpGaD
Eprosartan—AGTR1—blood—alcohol dependence	0.00305	0.0446	CbGeAlD
Eprosartan—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00294	0.0228	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00281	0.0218	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00271	0.021	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—ALDH3A1—alcohol dependence	0.00266	0.0206	CbGpPWpGaD
Eprosartan—AGTR1—endocrine gland—alcohol dependence	0.00265	0.0386	CbGeAlD
Eprosartan—AGTR1—testis—alcohol dependence	0.00252	0.0369	CbGeAlD
Eprosartan—AGTR1—nervous system—alcohol dependence	0.00248	0.0362	CbGeAlD
Eprosartan—Migraine—Naltrexone—alcohol dependence	0.00245	0.00465	CcSEcCtD
Eprosartan—Viral infection—Citalopram—alcohol dependence	0.0024	0.00457	CcSEcCtD
Eprosartan—Face oedema—Naltrexone—alcohol dependence	0.0024	0.00456	CcSEcCtD
Eprosartan—Orthostatic hypotension—Acamprosate—alcohol dependence	0.0024	0.00456	CcSEcCtD
Eprosartan—AGTR1—liver—alcohol dependence	0.00239	0.0348	CbGeAlD
Eprosartan—Arthropathy—Citalopram—alcohol dependence	0.00239	0.00454	CcSEcCtD
Eprosartan—AGTR1—central nervous system—alcohol dependence	0.00239	0.0348	CbGeAlD
Eprosartan—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00237	0.0045	CcSEcCtD
Eprosartan—Herpes simplex—Citalopram—alcohol dependence	0.00235	0.00448	CcSEcCtD
Eprosartan—Paraesthesia—Disulfiram—alcohol dependence	0.00235	0.00448	CcSEcCtD
Eprosartan—Somnolence—Disulfiram—alcohol dependence	0.00233	0.00443	CcSEcCtD
Eprosartan—Gastritis—Acamprosate—alcohol dependence	0.00232	0.00442	CcSEcCtD
Eprosartan—Gout—Citalopram—alcohol dependence	0.00232	0.00442	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00232	0.00441	CcSEcCtD
Eprosartan—ABCC2—digestive system—alcohol dependence	0.00232	0.0338	CbGeAlD
Eprosartan—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00229	0.00436	CcSEcCtD
Eprosartan—Asthma—Acamprosate—alcohol dependence	0.00227	0.00432	CcSEcCtD
Eprosartan—Bone pain—Citalopram—alcohol dependence	0.00226	0.00431	CcSEcCtD
Eprosartan—Fatigue—Disulfiram—alcohol dependence	0.00226	0.0043	CcSEcCtD
Eprosartan—Pain—Disulfiram—alcohol dependence	0.00224	0.00426	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00224	0.00426	CcSEcCtD
Eprosartan—Angina pectoris—Acamprosate—alcohol dependence	0.00221	0.00421	CcSEcCtD
Eprosartan—ABCC2—blood—alcohol dependence	0.00221	0.0322	CbGeAlD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.0022	0.0171	CbGpPWpGaD
Eprosartan—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00219	0.00417	CcSEcCtD
Eprosartan—Bronchitis—Acamprosate—alcohol dependence	0.00218	0.00415	CcSEcCtD
Eprosartan—Cystitis noninfective—Citalopram—alcohol dependence	0.00212	0.00403	CcSEcCtD
Eprosartan—Influenza like illness—Citalopram—alcohol dependence	0.00211	0.00401	CcSEcCtD
Eprosartan—Pollakiuria—Acamprosate—alcohol dependence	0.0021	0.00399	CcSEcCtD
Eprosartan—Urinary incontinence—Citalopram—alcohol dependence	0.00209	0.00399	CcSEcCtD
Eprosartan—Cystitis—Citalopram—alcohol dependence	0.00209	0.00399	CcSEcCtD
Eprosartan—Sweating increased—Naltrexone—alcohol dependence	0.00209	0.00398	CcSEcCtD
Eprosartan—Angina pectoris—Naltrexone—alcohol dependence	0.00209	0.00398	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00207	0.0161	CbGpPWpGaD
Eprosartan—Bronchitis—Naltrexone—alcohol dependence	0.00207	0.00393	CcSEcCtD
Eprosartan—Hyperglycaemia—Acamprosate—alcohol dependence	0.00205	0.0039	CcSEcCtD
Eprosartan—Depression—Acamprosate—alcohol dependence	0.00202	0.00384	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.002	0.0038	CcSEcCtD
Eprosartan—Cramps of lower extremities—Citalopram—alcohol dependence	0.00199	0.00379	CcSEcCtD
Eprosartan—Oesophagitis—Citalopram—alcohol dependence	0.00198	0.00377	CcSEcCtD
Eprosartan—Rash maculo-papular—Citalopram—alcohol dependence	0.00197	0.00375	CcSEcCtD
Eprosartan—Urinary tract infection—Acamprosate—alcohol dependence	0.00197	0.00374	CcSEcCtD
Eprosartan—Urine output increased—Citalopram—alcohol dependence	0.00196	0.00373	CcSEcCtD
Eprosartan—Bladder pain—Citalopram—alcohol dependence	0.00196	0.00373	CcSEcCtD
Eprosartan—Haematuria—Acamprosate—alcohol dependence	0.00193	0.00367	CcSEcCtD
Eprosartan—ABCC2—endocrine gland—alcohol dependence	0.00191	0.0279	CbGeAlD
Eprosartan—Depression—Naltrexone—alcohol dependence	0.00191	0.00363	CcSEcCtD
Eprosartan—Epistaxis—Acamprosate—alcohol dependence	0.00191	0.00363	CcSEcCtD
Eprosartan—AGTR1—brain—alcohol dependence	0.00189	0.0276	CbGeAlD
Eprosartan—Abnormal vision—Citalopram—alcohol dependence	0.00189	0.0036	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.00189	0.0147	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00188	0.0146	CbGpPWpGaD
Eprosartan—Asthenia—Disulfiram—alcohol dependence	0.00188	0.00358	CcSEcCtD
Eprosartan—Urinary tract infection—Naltrexone—alcohol dependence	0.00186	0.00354	CcSEcCtD
Eprosartan—Conjunctivitis—Naltrexone—alcohol dependence	0.00186	0.00354	CcSEcCtD
Eprosartan—CYP2C9—cardiovascular system—alcohol dependence	0.00186	0.0271	CbGeAlD
Eprosartan—ABCC2—testis—alcohol dependence	0.00182	0.0266	CbGeAlD
Eprosartan—Rhinitis—Acamprosate—alcohol dependence	0.00182	0.00347	CcSEcCtD
Eprosartan—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00182	0.0141	CbGpPWpGaD
Eprosartan—Diabetes mellitus—Citalopram—alcohol dependence	0.00181	0.00344	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00181	0.014	CbGpPWpGaD
Eprosartan—Epistaxis—Naltrexone—alcohol dependence	0.00181	0.00344	CcSEcCtD
Eprosartan—Pharyngitis—Acamprosate—alcohol dependence	0.0018	0.00343	CcSEcCtD
Eprosartan—Sinusitis—Naltrexone—alcohol dependence	0.0018	0.00342	CcSEcCtD
Eprosartan—Polyuria—Citalopram—alcohol dependence	0.00179	0.00341	CcSEcCtD
Eprosartan—Oedema peripheral—Acamprosate—alcohol dependence	0.00179	0.00341	CcSEcCtD
Eprosartan—Gastroenteritis—Citalopram—alcohol dependence	0.00178	0.00338	CcSEcCtD
Eprosartan—Vascular purpura—Citalopram—alcohol dependence	0.00176	0.00335	CcSEcCtD
Eprosartan—Eczema—Citalopram—alcohol dependence	0.00175	0.00333	CcSEcCtD
Eprosartan—Visual impairment—Acamprosate—alcohol dependence	0.00175	0.00333	CcSEcCtD
Eprosartan—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00175	0.0136	CbGpPWpGaD
Eprosartan—Dizziness—Disulfiram—alcohol dependence	0.00173	0.0033	CcSEcCtD
Eprosartan—ABCC2—liver—alcohol dependence	0.00173	0.0252	CbGeAlD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00172	0.0133	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—ADH7—alcohol dependence	0.00171	0.0133	CbGpPWpGaD
Eprosartan—Pharyngitis—Naltrexone—alcohol dependence	0.00171	0.00325	CcSEcCtD
Eprosartan—Tinnitus—Acamprosate—alcohol dependence	0.00169	0.00322	CcSEcCtD
Eprosartan—Hot flush—Citalopram—alcohol dependence	0.00168	0.0032	CcSEcCtD
Eprosartan—Menopausal symptoms—Citalopram—alcohol dependence	0.00167	0.00318	CcSEcCtD
Eprosartan—Atrial fibrillation—Citalopram—alcohol dependence	0.00166	0.00316	CcSEcCtD
Eprosartan—Rash—Disulfiram—alcohol dependence	0.00165	0.00314	CcSEcCtD
Eprosartan—Headache—Disulfiram—alcohol dependence	0.00164	0.00312	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—GGT2—alcohol dependence	0.00164	0.0127	CbGpPWpGaD
Eprosartan—Purpura—Citalopram—alcohol dependence	0.00163	0.00311	CcSEcCtD
Eprosartan—Chills—Acamprosate—alcohol dependence	0.00163	0.0031	CcSEcCtD
Eprosartan—Arthritis—Citalopram—alcohol dependence	0.00162	0.00308	CcSEcCtD
Eprosartan—Cardiac failure—Citalopram—alcohol dependence	0.00161	0.00307	CcSEcCtD
Eprosartan—Tinnitus—Naltrexone—alcohol dependence	0.0016	0.00305	CcSEcCtD
Eprosartan—Hyponatraemia—Citalopram—alcohol dependence	0.00158	0.00301	CcSEcCtD
Eprosartan—Osteoarthritis—Citalopram—alcohol dependence	0.00157	0.003	CcSEcCtD
Eprosartan—Flatulence—Acamprosate—alcohol dependence	0.00156	0.00297	CcSEcCtD
Eprosartan—Tension—Acamprosate—alcohol dependence	0.00155	0.00295	CcSEcCtD
Eprosartan—Migraine—Citalopram—alcohol dependence	0.00155	0.00295	CcSEcCtD
Eprosartan—CYP2C9—digestive system—alcohol dependence	0.00154	0.0225	CbGeAlD
Eprosartan—Chills—Naltrexone—alcohol dependence	0.00154	0.00294	CcSEcCtD
Eprosartan—Nervousness—Acamprosate—alcohol dependence	0.00154	0.00292	CcSEcCtD
Eprosartan—Back pain—Acamprosate—alcohol dependence	0.00153	0.00291	CcSEcCtD
Eprosartan—Muscle spasms—Acamprosate—alcohol dependence	0.00152	0.00289	CcSEcCtD
Eprosartan—Face oedema—Citalopram—alcohol dependence	0.00152	0.00289	CcSEcCtD
Eprosartan—Tremor—Acamprosate—alcohol dependence	0.00148	0.00282	CcSEcCtD
Eprosartan—Ataxia—Citalopram—alcohol dependence	0.00148	0.00282	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00148	0.0115	CbGpPWpGaD
Eprosartan—Flatulence—Naltrexone—alcohol dependence	0.00147	0.00281	CcSEcCtD
Eprosartan—CYP2C9—blood—alcohol dependence	0.00147	0.0215	CbGeAlD
Eprosartan—Tension—Naltrexone—alcohol dependence	0.00147	0.00279	CcSEcCtD
Eprosartan—Ill-defined disorder—Acamprosate—alcohol dependence	0.00147	0.00279	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00146	0.0113	CbGpPWpGaD
Eprosartan—Nervousness—Naltrexone—alcohol dependence	0.00145	0.00277	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00145	0.0113	CbGpPWpGaD
Eprosartan—Back pain—Naltrexone—alcohol dependence	0.00145	0.00275	CcSEcCtD
Eprosartan—Angioedema—Acamprosate—alcohol dependence	0.00145	0.00275	CcSEcCtD
Eprosartan—Muscle spasms—Naltrexone—alcohol dependence	0.00144	0.00274	CcSEcCtD
Eprosartan—Orthostatic hypotension—Citalopram—alcohol dependence	0.00144	0.00274	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—OPRK1—alcohol dependence	0.00143	0.0111	CbGpPWpGaD
Eprosartan—Hypokalaemia—Citalopram—alcohol dependence	0.00143	0.00273	CcSEcCtD
Eprosartan—Malaise—Acamprosate—alcohol dependence	0.00143	0.00271	CcSEcCtD
Eprosartan—Vertigo—Acamprosate—alcohol dependence	0.00142	0.0027	CcSEcCtD
Eprosartan—Syncope—Acamprosate—alcohol dependence	0.00142	0.0027	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00142	0.0027	CcSEcCtD
Eprosartan—Tremor—Naltrexone—alcohol dependence	0.0014	0.00267	CcSEcCtD
Eprosartan—Palpitations—Acamprosate—alcohol dependence	0.0014	0.00266	CcSEcCtD
Eprosartan—Gastritis—Citalopram—alcohol dependence	0.00139	0.00265	CcSEcCtD
Eprosartan—Loss of consciousness—Acamprosate—alcohol dependence	0.00139	0.00265	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00139	0.00264	CcSEcCtD
Eprosartan—Muscular weakness—Citalopram—alcohol dependence	0.00139	0.00264	CcSEcCtD
Eprosartan—Ill-defined disorder—Naltrexone—alcohol dependence	0.00139	0.00264	CcSEcCtD
Eprosartan—Cough—Acamprosate—alcohol dependence	0.00138	0.00263	CcSEcCtD
Eprosartan—Angioedema—Naltrexone—alcohol dependence	0.00137	0.0026	CcSEcCtD
Eprosartan—Asthma—Citalopram—alcohol dependence	0.00136	0.00259	CcSEcCtD
Eprosartan—Malaise—Naltrexone—alcohol dependence	0.00135	0.00257	CcSEcCtD
Eprosartan—Arthralgia—Acamprosate—alcohol dependence	0.00135	0.00256	CcSEcCtD
Eprosartan—Myalgia—Acamprosate—alcohol dependence	0.00135	0.00256	CcSEcCtD
Eprosartan—Chest pain—Acamprosate—alcohol dependence	0.00135	0.00256	CcSEcCtD
Eprosartan—Syncope—Naltrexone—alcohol dependence	0.00134	0.00255	CcSEcCtD
Eprosartan—Anxiety—Acamprosate—alcohol dependence	0.00134	0.00255	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00134	0.0104	CbGpPWpGaD
Eprosartan—Discomfort—Acamprosate—alcohol dependence	0.00133	0.00253	CcSEcCtD
Eprosartan—Sweating increased—Citalopram—alcohol dependence	0.00133	0.00252	CcSEcCtD
Eprosartan—Angina pectoris—Citalopram—alcohol dependence	0.00133	0.00252	CcSEcCtD
Eprosartan—Palpitations—Naltrexone—alcohol dependence	0.00132	0.00252	CcSEcCtD
Eprosartan—Dry mouth—Acamprosate—alcohol dependence	0.00132	0.00251	CcSEcCtD
Eprosartan—Loss of consciousness—Naltrexone—alcohol dependence	0.00132	0.0025	CcSEcCtD
Eprosartan—Bronchitis—Citalopram—alcohol dependence	0.00131	0.00249	CcSEcCtD
Eprosartan—Cough—Naltrexone—alcohol dependence	0.00131	0.00248	CcSEcCtD
Eprosartan—CYP2C9—endocrine gland—alcohol dependence	0.00127	0.0186	CbGeAlD
Eprosartan—Arthralgia—Naltrexone—alcohol dependence	0.00127	0.00242	CcSEcCtD
Eprosartan—Chest pain—Naltrexone—alcohol dependence	0.00127	0.00242	CcSEcCtD
Eprosartan—Myalgia—Naltrexone—alcohol dependence	0.00127	0.00242	CcSEcCtD
Eprosartan—Shock—Acamprosate—alcohol dependence	0.00127	0.00242	CcSEcCtD
Eprosartan—Anxiety—Naltrexone—alcohol dependence	0.00127	0.00242	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00127	0.00983	CbGpPWpGaD
Eprosartan—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00127	0.00241	CcSEcCtD
Eprosartan—Thrombocytopenia—Acamprosate—alcohol dependence	0.00126	0.00241	CcSEcCtD
Eprosartan—Tachycardia—Acamprosate—alcohol dependence	0.00126	0.0024	CcSEcCtD
Eprosartan—Discomfort—Naltrexone—alcohol dependence	0.00126	0.0024	CcSEcCtD
Eprosartan—Pollakiuria—Citalopram—alcohol dependence	0.00126	0.00239	CcSEcCtD
Eprosartan—Hyperhidrosis—Acamprosate—alcohol dependence	0.00125	0.00237	CcSEcCtD
Eprosartan—Dry mouth—Naltrexone—alcohol dependence	0.00125	0.00237	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00124	0.00963	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00124	0.00961	CbGpPWpGaD
Eprosartan—Anorexia—Acamprosate—alcohol dependence	0.00123	0.00234	CcSEcCtD
Eprosartan—Hyperglycaemia—Citalopram—alcohol dependence	0.00123	0.00234	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00121	0.00942	CbGpPWpGaD
Eprosartan—Depression—Citalopram—alcohol dependence	0.00121	0.0023	CcSEcCtD
Eprosartan—Hypotension—Acamprosate—alcohol dependence	0.00121	0.0023	CcSEcCtD
Eprosartan—Shock—Naltrexone—alcohol dependence	0.0012	0.00229	CcSEcCtD
Eprosartan—Tachycardia—Naltrexone—alcohol dependence	0.00119	0.00227	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00119	0.00924	CbGpPWpGaD
Eprosartan—Neuropathy peripheral—Citalopram—alcohol dependence	0.00119	0.00226	CcSEcCtD
Eprosartan—Hyperhidrosis—Naltrexone—alcohol dependence	0.00118	0.00225	CcSEcCtD
Eprosartan—Urinary tract infection—Citalopram—alcohol dependence	0.00118	0.00224	CcSEcCtD
Eprosartan—Conjunctivitis—Citalopram—alcohol dependence	0.00118	0.00224	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00118	0.00224	CcSEcCtD
Eprosartan—Insomnia—Acamprosate—alcohol dependence	0.00117	0.00222	CcSEcCtD
Eprosartan—Anorexia—Naltrexone—alcohol dependence	0.00116	0.00222	CcSEcCtD
Eprosartan—Paraesthesia—Acamprosate—alcohol dependence	0.00116	0.00221	CcSEcCtD
Eprosartan—Haematuria—Citalopram—alcohol dependence	0.00116	0.0022	CcSEcCtD
Eprosartan—Dyspnoea—Acamprosate—alcohol dependence	0.00115	0.00219	CcSEcCtD
Eprosartan—CYP2C9—liver—alcohol dependence	0.00115	0.0168	CbGeAlD
Eprosartan—Somnolence—Acamprosate—alcohol dependence	0.00115	0.00218	CcSEcCtD
Eprosartan—Epistaxis—Citalopram—alcohol dependence	0.00114	0.00218	CcSEcCtD
Eprosartan—Sinusitis—Citalopram—alcohol dependence	0.00114	0.00217	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00114	0.00883	CbGpPWpGaD
Eprosartan—Dyspepsia—Acamprosate—alcohol dependence	0.00114	0.00216	CcSEcCtD
Eprosartan—Decreased appetite—Acamprosate—alcohol dependence	0.00112	0.00214	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00111	0.00212	CcSEcCtD
Eprosartan—Bradycardia—Citalopram—alcohol dependence	0.00111	0.00211	CcSEcCtD
Eprosartan—Insomnia—Naltrexone—alcohol dependence	0.0011	0.0021	CcSEcCtD
Eprosartan—Pain—Acamprosate—alcohol dependence	0.0011	0.0021	CcSEcCtD
Eprosartan—Constipation—Acamprosate—alcohol dependence	0.0011	0.0021	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.0011	0.00854	CbGpPWpGaD
Eprosartan—Paraesthesia—Naltrexone—alcohol dependence	0.0011	0.00209	CcSEcCtD
Eprosartan—Rhinitis—Citalopram—alcohol dependence	0.00109	0.00208	CcSEcCtD
Eprosartan—Dyspnoea—Naltrexone—alcohol dependence	0.00109	0.00207	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00109	0.00845	CbGpPWpGaD
Eprosartan—Somnolence—Naltrexone—alcohol dependence	0.00109	0.00207	CcSEcCtD
Eprosartan—Pharyngitis—Citalopram—alcohol dependence	0.00108	0.00206	CcSEcCtD
Eprosartan—Oedema peripheral—Citalopram—alcohol dependence	0.00107	0.00204	CcSEcCtD
Eprosartan—Feeling abnormal—Acamprosate—alcohol dependence	0.00106	0.00202	CcSEcCtD
Eprosartan—Decreased appetite—Naltrexone—alcohol dependence	0.00106	0.00202	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00106	0.00824	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00106	0.00201	CcSEcCtD
Eprosartan—Fatigue—Naltrexone—alcohol dependence	0.00105	0.002	CcSEcCtD
Eprosartan—Visual impairment—Citalopram—alcohol dependence	0.00105	0.002	CcSEcCtD
Eprosartan—Pain—Naltrexone—alcohol dependence	0.00104	0.00199	CcSEcCtD
Eprosartan—Constipation—Naltrexone—alcohol dependence	0.00104	0.00199	CcSEcCtD
Eprosartan—Urticaria—Acamprosate—alcohol dependence	0.00103	0.00195	CcSEcCtD
Eprosartan—Body temperature increased—Acamprosate—alcohol dependence	0.00102	0.00194	CcSEcCtD
Eprosartan—Abdominal pain—Acamprosate—alcohol dependence	0.00102	0.00194	CcSEcCtD
Eprosartan—Tinnitus—Citalopram—alcohol dependence	0.00102	0.00193	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00101	0.00784	CbGpPWpGaD
Eprosartan—Feeling abnormal—Naltrexone—alcohol dependence	0.00101	0.00192	CcSEcCtD
Eprosartan—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000999	0.0019	CcSEcCtD
Eprosartan—Chills—Citalopram—alcohol dependence	0.000978	0.00186	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000974	0.00756	CbGpPWpGaD
Eprosartan—Urticaria—Naltrexone—alcohol dependence	0.00097	0.00185	CcSEcCtD
Eprosartan—Abdominal pain—Naltrexone—alcohol dependence	0.000966	0.00184	CcSEcCtD
Eprosartan—Body temperature increased—Naltrexone—alcohol dependence	0.000966	0.00184	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—OPRD1—alcohol dependence	0.000964	0.00749	CbGpPWpGaD
Eprosartan—Hypersensitivity—Acamprosate—alcohol dependence	0.000951	0.00181	CcSEcCtD
Eprosartan—Flatulence—Citalopram—alcohol dependence	0.000935	0.00178	CcSEcCtD
Eprosartan—Tension—Citalopram—alcohol dependence	0.000931	0.00177	CcSEcCtD
Eprosartan—Asthenia—Acamprosate—alcohol dependence	0.000926	0.00176	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—PDYN—alcohol dependence	0.000925	0.00718	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A4—alcohol dependence	0.000924	0.00717	CbGpPWpGaD
Eprosartan—Nervousness—Citalopram—alcohol dependence	0.000921	0.00175	CcSEcCtD
Eprosartan—Back pain—Citalopram—alcohol dependence	0.000917	0.00175	CcSEcCtD
Eprosartan—Pruritus—Acamprosate—alcohol dependence	0.000913	0.00174	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000912	0.00708	CbGpPWpGaD
Eprosartan—Muscle spasms—Citalopram—alcohol dependence	0.000912	0.00173	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000902	0.007	CbGpPWpGaD
Eprosartan—Hypersensitivity—Naltrexone—alcohol dependence	0.0009	0.00171	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000897	0.00696	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—AVP—alcohol dependence	0.000895	0.00695	CbGpPWpGaD
Eprosartan—Tremor—Citalopram—alcohol dependence	0.000889	0.00169	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AVP—alcohol dependence	0.000884	0.00686	CbGpPWpGaD
Eprosartan—Diarrhoea—Acamprosate—alcohol dependence	0.000883	0.00168	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000883	0.00685	CbGpPWpGaD
Eprosartan—Ill-defined disorder—Citalopram—alcohol dependence	0.00088	0.00167	CcSEcCtD
Eprosartan—Asthenia—Naltrexone—alcohol dependence	0.000876	0.00167	CcSEcCtD
Eprosartan—Angioedema—Citalopram—alcohol dependence	0.000867	0.00165	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000865	0.00671	CbGpPWpGaD
Eprosartan—Pruritus—Naltrexone—alcohol dependence	0.000864	0.00164	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CRHR1—alcohol dependence	0.00086	0.00667	CbGpPWpGaD
Eprosartan—Malaise—Citalopram—alcohol dependence	0.000855	0.00163	CcSEcCtD
Eprosartan—Dizziness—Acamprosate—alcohol dependence	0.000854	0.00162	CcSEcCtD
Eprosartan—Vertigo—Citalopram—alcohol dependence	0.000852	0.00162	CcSEcCtD
Eprosartan—Syncope—Citalopram—alcohol dependence	0.00085	0.00162	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000843	0.00654	CbGpPWpGaD
Eprosartan—Palpitations—Citalopram—alcohol dependence	0.000838	0.00159	CcSEcCtD
Eprosartan—Diarrhoea—Naltrexone—alcohol dependence	0.000836	0.00159	CcSEcCtD
Eprosartan—Loss of consciousness—Citalopram—alcohol dependence	0.000834	0.00159	CcSEcCtD
Eprosartan—Cough—Citalopram—alcohol dependence	0.000828	0.00157	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—SLC6A3—alcohol dependence	0.000824	0.00639	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000822	0.00638	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000822	0.00638	CbGpPWpGaD
Eprosartan—Vomiting—Acamprosate—alcohol dependence	0.000821	0.00156	CcSEcCtD
Eprosartan—Rash—Acamprosate—alcohol dependence	0.000814	0.00155	CcSEcCtD
Eprosartan—Dermatitis—Acamprosate—alcohol dependence	0.000813	0.00155	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—OPRK1—alcohol dependence	0.000811	0.00629	CbGpPWpGaD
Eprosartan—Headache—Acamprosate—alcohol dependence	0.000809	0.00154	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CHRM2—alcohol dependence	0.000808	0.00627	CbGpPWpGaD
Eprosartan—Dizziness—Naltrexone—alcohol dependence	0.000808	0.00154	CcSEcCtD
Eprosartan—Arthralgia—Citalopram—alcohol dependence	0.000807	0.00154	CcSEcCtD
Eprosartan—Myalgia—Citalopram—alcohol dependence	0.000807	0.00154	CcSEcCtD
Eprosartan—Chest pain—Citalopram—alcohol dependence	0.000807	0.00154	CcSEcCtD
Eprosartan—Anxiety—Citalopram—alcohol dependence	0.000805	0.00153	CcSEcCtD
Eprosartan—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000803	0.00623	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000801	0.00622	CbGpPWpGaD
Eprosartan—Discomfort—Citalopram—alcohol dependence	0.000798	0.00152	CcSEcCtD
Eprosartan—Dry mouth—Citalopram—alcohol dependence	0.00079	0.0015	CcSEcCtD
Eprosartan—Vomiting—Naltrexone—alcohol dependence	0.000777	0.00148	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—GGT1—alcohol dependence	0.000776	0.00602	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000775	0.00602	CbGpPWpGaD
Eprosartan—Rash—Naltrexone—alcohol dependence	0.00077	0.00147	CcSEcCtD
Eprosartan—Dermatitis—Naltrexone—alcohol dependence	0.00077	0.00146	CcSEcCtD
Eprosartan—Nausea—Acamprosate—alcohol dependence	0.000767	0.00146	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000767	0.00595	CbGpPWpGaD
Eprosartan—Headache—Naltrexone—alcohol dependence	0.000765	0.00146	CcSEcCtD
Eprosartan—Shock—Citalopram—alcohol dependence	0.000762	0.00145	CcSEcCtD
Eprosartan—Thrombocytopenia—Citalopram—alcohol dependence	0.000758	0.00144	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000756	0.00587	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000756	0.00587	CbGpPWpGaD
Eprosartan—Tachycardia—Citalopram—alcohol dependence	0.000755	0.00144	CcSEcCtD
Eprosartan—Hyperhidrosis—Citalopram—alcohol dependence	0.000748	0.00142	CcSEcCtD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000746	0.00579	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—alcohol dependence	0.000745	0.00578	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OPRM1—alcohol dependence	0.000742	0.00576	CbGpPWpGaD
Eprosartan—Anorexia—Citalopram—alcohol dependence	0.000738	0.0014	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—OPRK1—alcohol dependence	0.000736	0.00571	CbGpPWpGaD
Eprosartan—Nausea—Naltrexone—alcohol dependence	0.000726	0.00138	CcSEcCtD
Eprosartan—Hypotension—Citalopram—alcohol dependence	0.000723	0.00138	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000722	0.0056	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000705	0.00134	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000704	0.00547	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000704	0.00547	CbGpPWpGaD
Eprosartan—Insomnia—Citalopram—alcohol dependence	0.0007	0.00133	CcSEcCtD
Eprosartan—Paraesthesia—Citalopram—alcohol dependence	0.000695	0.00132	CcSEcCtD
Eprosartan—Dyspnoea—Citalopram—alcohol dependence	0.00069	0.00131	CcSEcCtD
Eprosartan—Somnolence—Citalopram—alcohol dependence	0.000688	0.00131	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—NPY—alcohol dependence	0.000683	0.0053	CbGpPWpGaD
Eprosartan—Dyspepsia—Citalopram—alcohol dependence	0.000681	0.0013	CcSEcCtD
Eprosartan—Decreased appetite—Citalopram—alcohol dependence	0.000673	0.00128	CcSEcCtD
Eprosartan—Fatigue—Citalopram—alcohol dependence	0.000667	0.00127	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000666	0.00517	CbGpPWpGaD
Eprosartan—Pain—Citalopram—alcohol dependence	0.000662	0.00126	CcSEcCtD
Eprosartan—Constipation—Citalopram—alcohol dependence	0.000662	0.00126	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000659	0.00512	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR1B—alcohol dependence	0.000659	0.00511	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CRH—alcohol dependence	0.000659	0.00511	CbGpPWpGaD
Eprosartan—Feeling abnormal—Citalopram—alcohol dependence	0.000638	0.00121	CcSEcCtD
Eprosartan—Gastrointestinal pain—Citalopram—alcohol dependence	0.000633	0.0012	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000632	0.00491	CbGpPWpGaD
Eprosartan—Urticaria—Citalopram—alcohol dependence	0.000615	0.00117	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000613	0.00476	CbGpPWpGaD
Eprosartan—Abdominal pain—Citalopram—alcohol dependence	0.000612	0.00116	CcSEcCtD
Eprosartan—Body temperature increased—Citalopram—alcohol dependence	0.000612	0.00116	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000593	0.0046	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000587	0.00456	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000578	0.00449	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000576	0.00447	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD4—alcohol dependence	0.000576	0.00447	CbGpPWpGaD
Eprosartan—Hypersensitivity—Citalopram—alcohol dependence	0.00057	0.00108	CcSEcCtD
Eprosartan—Asthenia—Citalopram—alcohol dependence	0.000555	0.00106	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CNR1—alcohol dependence	0.00055	0.00427	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000548	0.00425	CbGpPWpGaD
Eprosartan—Pruritus—Citalopram—alcohol dependence	0.000548	0.00104	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—OPRD1—alcohol dependence	0.000545	0.00423	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR7—alcohol dependence	0.000536	0.00416	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD2—alcohol dependence	0.000536	0.00416	CbGpPWpGaD
Eprosartan—Diarrhoea—Citalopram—alcohol dependence	0.00053	0.00101	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—PDYN—alcohol dependence	0.000523	0.00406	CbGpPWpGaD
Eprosartan—Dizziness—Citalopram—alcohol dependence	0.000512	0.000974	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000504	0.00391	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OPRD1—alcohol dependence	0.000495	0.00384	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000493	0.00383	CbGpPWpGaD
Eprosartan—Vomiting—Citalopram—alcohol dependence	0.000492	0.000936	CcSEcCtD
Eprosartan—Rash—Citalopram—alcohol dependence	0.000488	0.000928	CcSEcCtD
Eprosartan—Dermatitis—Citalopram—alcohol dependence	0.000488	0.000928	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CRHR1—alcohol dependence	0.000486	0.00377	CbGpPWpGaD
Eprosartan—Headache—Citalopram—alcohol dependence	0.000485	0.000922	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000479	0.00372	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDYN—alcohol dependence	0.000474	0.00368	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000466	0.00362	CbGpPWpGaD
Eprosartan—Nausea—Citalopram—alcohol dependence	0.00046	0.000875	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CHRM2—alcohol dependence	0.000457	0.00354	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AVP—alcohol dependence	0.000452	0.0035	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CRHR1—alcohol dependence	0.000441	0.00342	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OPRK1—alcohol dependence	0.000435	0.00338	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OPRM1—alcohol dependence	0.000419	0.00325	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CHRM2—alcohol dependence	0.000415	0.00322	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000407	0.00316	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000405	0.00314	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000394	0.00306	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPY—alcohol dependence	0.000386	0.003	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OPRM1—alcohol dependence	0.000381	0.00296	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—alcohol dependence	0.000376	0.00292	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CRH—alcohol dependence	0.000372	0.00289	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1B—alcohol dependence	0.000372	0.00289	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPY—alcohol dependence	0.00035	0.00272	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CRH—alcohol dependence	0.000338	0.00262	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1B—alcohol dependence	0.000338	0.00262	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000328	0.00255	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000326	0.00253	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD4—alcohol dependence	0.000325	0.00253	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000321	0.00249	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CNR1—alcohol dependence	0.000311	0.00241	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD2—alcohol dependence	0.000303	0.00235	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR7—alcohol dependence	0.000303	0.00235	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—POMC—alcohol dependence	0.0003	0.00233	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000299	0.00232	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD4—alcohol dependence	0.000296	0.00229	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OPRD1—alcohol dependence	0.000292	0.00227	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CNR1—alcohol dependence	0.000282	0.00219	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDYN—alcohol dependence	0.00028	0.00218	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD2—alcohol dependence	0.000275	0.00214	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR7—alcohol dependence	0.000275	0.00214	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000268	0.00208	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000264	0.00205	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRHR1—alcohol dependence	0.000261	0.00202	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—WASF2—alcohol dependence	0.000261	0.00202	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AVP—alcohol dependence	0.000255	0.00198	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—WASF1—alcohol dependence	0.00025	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CHRM2—alcohol dependence	0.000245	0.0019	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AVP—alcohol dependence	0.000232	0.0018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OPRM1—alcohol dependence	0.000225	0.00175	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000218	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000212	0.00165	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPY—alcohol dependence	0.000207	0.00161	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1B—alcohol dependence	0.0002	0.00155	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRH—alcohol dependence	0.0002	0.00155	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—alcohol dependence	0.000193	0.0015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000188	0.00146	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD4—alcohol dependence	0.000175	0.00135	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000174	0.00135	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—alcohol dependence	0.00017	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR1—alcohol dependence	0.000167	0.00129	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD2—alcohol dependence	0.000163	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR7—alcohol dependence	0.000163	0.00126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH1A—alcohol dependence	0.000156	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—alcohol dependence	0.000154	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AVP—alcohol dependence	0.000137	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH4—alcohol dependence	0.000133	0.00103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000115	0.000891	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—alcohol dependence	0.000114	0.000884	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH7—alcohol dependence	0.000113	0.000875	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGT2—alcohol dependence	0.000108	0.000839	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH1B—alcohol dependence	9.89e-05	0.000767	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—alcohol dependence	9.1e-05	0.000706	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOB—alcohol dependence	8.19e-05	0.000636	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH2—alcohol dependence	6.97e-05	0.000541	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.7e-05	0.00052	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EP300—alcohol dependence	6.03e-05	0.000468	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT2—alcohol dependence	5.92e-05	0.00046	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2E1—alcohol dependence	5.57e-05	0.000432	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGT1—alcohol dependence	5.11e-05	0.000397	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT1—alcohol dependence	5.11e-05	0.000397	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOA—alcohol dependence	4.58e-05	0.000356	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.44e-05	0.000345	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—alcohol dependence	2.98e-05	0.000232	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—EP300—alcohol dependence	1.98e-05	0.000154	CbGpPWpGaD
